IMVT logo

Immunovant (IMVT) Earnings Per Share

Annual EPS

-$1.88
-$0.17-9.94%

March 31, 2024


Summary


Performance

IMVT EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTprofitabilitymetrics:

Quarterly EPS

-$0.76
-$0.02-2.70%

December 31, 2024


Summary


Performance

IMVT Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTprofitabilitymetrics:

TTM EPS

-$2.62
-$0.40-18.02%

December 31, 2024


Summary


Performance

IMVT TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTprofitabilitymetrics:

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

IMVT EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.9%-111.1%-42.4%
3 y3 years-54.1%-111.1%-101.5%
5 y5 years-22.1%-171.4%-913.1%

IMVT EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-54.1%at low-117.1%at low-101.5%at low
5 y5-year-54.1%at low-204.0%at low-913.1%at low
alltimeall time-54.1%at low-6084.3%at low<-9999.0%at low

Immunovant EPS History

DateAnnualQuarterlyTTM
Dec 2024
-
-$0.76(+2.7%)
-$2.62(+18.0%)
Sep 2024
-
-$0.74(+23.3%)
-$2.22(+15.0%)
Jun 2024
-
-$0.60(+15.4%)
-$1.93(+1.6%)
Mar 2024
-$1.88(+9.9%)
-$0.52(+44.4%)
-$1.90(+3.3%)
Dec 2023
-
-$0.36(-20.0%)
-$1.84(-6.6%)
Sep 2023
-
-$0.45(-21.1%)
-$1.97(+2.1%)
Jun 2023
-
-$0.57(+23.9%)
-$1.93(+12.9%)
Mar 2023
-$1.71(+19.6%)
-$0.46(-6.1%)
-$1.71(+3.0%)
Dec 2022
-
-$0.49(+19.5%)
-$1.66(+8.5%)
Sep 2022
-
-$0.41(+17.1%)
-$1.53(+4.1%)
Jun 2022
-
-$0.35(-14.6%)
-$1.47(+2.8%)
Mar 2022
-$1.43
-$0.41(+13.9%)
-$1.43(+10.0%)
DateAnnualQuarterlyTTM
Dec 2021
-
-$0.36(+2.9%)
-$1.30(+3.2%)
Sep 2021
-
-$0.35(+12.9%)
-$1.26(+8.6%)
Jun 2021
-
-$0.31(+10.7%)
-$1.16(-5.7%)
Mar 2021
-$1.22(-20.8%)
-$0.28(-12.5%)
-$1.23(-7.5%)
Dec 2020
-
-$0.32(+28.0%)
-$1.33(+3.1%)
Sep 2020
-
-$0.25(-34.2%)
-$1.29(+25.1%)
Jun 2020
-
-$0.38(0.0%)
-$1.03(+61.5%)
Mar 2020
-$1.54
-$0.38(+35.7%)
-$0.64(+146.9%)
Dec 2019
-
-$0.28(-3318.4%)
-$0.26(-1308.4%)
Sep 2019
-
$0.01(-31.5%)
$0.02(+68.5%)
Jun 2019
-
$0.01(>+9900.0%)
$0.01(>+9900.0%)
Mar 2019
-
$0.00
$0.00

FAQ

  • What is Immunovant annual earnings per share?
  • What is the all time high annual EPS for Immunovant?
  • What is Immunovant annual EPS year-on-year change?
  • What is Immunovant quarterly earnings per share?
  • What is the all time high quarterly EPS for Immunovant?
  • What is Immunovant quarterly EPS year-on-year change?
  • What is Immunovant TTM earnings per share?
  • What is the all time high TTM EPS for Immunovant?
  • What is Immunovant TTM EPS year-on-year change?

What is Immunovant annual earnings per share?

The current annual EPS of IMVT is -$1.88

What is the all time high annual EPS for Immunovant?

Immunovant all-time high annual earnings per share is -$1.22

What is Immunovant annual EPS year-on-year change?

Over the past year, IMVT annual earnings per share has changed by -$0.17 (-9.94%)

What is Immunovant quarterly earnings per share?

The current quarterly EPS of IMVT is -$0.76

What is the all time high quarterly EPS for Immunovant?

Immunovant all-time high quarterly earnings per share is $0.01

What is Immunovant quarterly EPS year-on-year change?

Over the past year, IMVT quarterly earnings per share has changed by -$0.40 (-111.11%)

What is Immunovant TTM earnings per share?

The current TTM EPS of IMVT is -$2.62

What is the all time high TTM EPS for Immunovant?

Immunovant all-time high TTM earnings per share is $0.02

What is Immunovant TTM EPS year-on-year change?

Over the past year, IMVT TTM earnings per share has changed by -$0.78 (-42.39%)